Two studies led by IDIBELL, the Catalan Institute of Oncology and the Bellvitge Hospital show that DNA sequencing in these samples can detect endometrial cancer, which would avoid much more invasive a...
Read morePeptomyc has received full study approval for its Phase Ib clinical trial evaluating the combination of its first-in-class MYC inhibitor Omomyc (OMO-103) with standard of care in metastatic pancreatic...
Read moreThe “MucOncoBots” project has a primary objective of employing nanobots to transport a specialized drug for the treatment of peritoneal pseudomyxoma (PMP). This rare disease is distinguished by th...
Read moreEl Hospital Clínico de València es pionero en la implantación de este método como alternativa, en sustitución del drenaje postoperatorio, que supone mayor riesgo de infección, complicaciones y m...
Read moreHan descubierto que unas proteínas denominadas SR pueden utilizarse como biomarcadores para detectar aquellos pacientes con leucemia mieloide aguda que muestran resistencia a la terapia estándar con...
Read moreResearchers at the Centre for Genomic Regulation (CRG) have uncovered new molecular determinants that underlie how pluripotent cells, which can differentiate into any type of cell in the body, decide ...
Read moreResearch by the Spanish National Cancer Research Centre (CNIO) has found a protein that may indicate when multiple neurofibromatosis tumours become malignant, and explores a treatment option.
Read moreSe ha desarrollado un nuevo sistema para predecir la evolución de los tumores de endometrio de bajo grado. Este nuevo procedimiento, desarrollado en el Cima y basado en la inteligencia artificial, pe...
Read moreEn el Biobanco del CNIO recae la dirección del nodo español de la Infraestructura Europea de Biobancos, que pone a disposición de la comunidad científica las muestras de 700 biobancos de 24 paíse...
Read moreHan desarrollado una nueva técnica para aislar y detectar el ADN libre proveniente de tumores cerebrales en muestras de orina. Su trabajo, publicado el pasado mes de julio en la revista Biosensors an...
Read moreResearchers at the Hospital Clínic-IDIBAPS led an international study, published in the journal The Lancet, in which they designed an index to determine the risk in the general population of developi...
Read moreThe development of future clinical trials to validate and confirm the action of ranolazine in cancer patients will be facilitated by the fact that it has already been approved for use in humans and is...
Read more